Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type Of Synthesis (Biotech, Synthetic), By Type Of Manufacturer (Captive, Merchant), By Type, By Application, By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Active Pharmaceutical Ingredients Market Growth & Trends
The global active pharmaceutical ingredients market size is expected to reach USD 353.0 billion by 2030, expanding at a compound annual growth rate (CAGR) of 6.0% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical Ingredients (API) manufacturing, and an increase in the geriatric population.
The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in-house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.
The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.
The active pharmaceutical Ingredients market was positively influenced by the COVID-19 pandemic, as countries and significant players produce large quantities of components to meet the demand for the treatment of COVID-19. As a result of the outbreak, drug companies have changed the companies’ strategies to focus on a larger patient population. To treat coronavirus, the U.S., for example, requested that HCQ be imported from India. The virus has also impacted Canada's medicine supply system, potentially causing complications for patients. The increasing importance of generics, rise in consumption of biopharmaceuticals, and expanding drug research and development activities for drug manufacturing are the primary drivers driving the growth of the market. However, the market's expansion is likely to be hampered by unfavorable drug price control regimes in several countries and high manufacturing costs.
Developing nations like India are receiving an increased preference in the market over dominant API market countries, like China, owing to geopolitical situations. Furthermore, India has quality raw materials and products, a large workforce, a vast distribution network, and government subsidies through the "Make in India" program.
To address unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In November 2021, Merck & Co Inc. announced that it has acquired Acceleron Pharma, this acquisition would help Merck & Co to expand their cardiovascular portfolio and pipeline.
Active Pharmaceutical Ingredients Market Report Highlights
Active Pharmaceutical Ingredients Market Growth & Trends
The global active pharmaceutical ingredients market size is expected to reach USD 353.0 billion by 2030, expanding at a compound annual growth rate (CAGR) of 6.0% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical Ingredients (API) manufacturing, and an increase in the geriatric population.
The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in-house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.
The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.
The active pharmaceutical Ingredients market was positively influenced by the COVID-19 pandemic, as countries and significant players produce large quantities of components to meet the demand for the treatment of COVID-19. As a result of the outbreak, drug companies have changed the companies’ strategies to focus on a larger patient population. To treat coronavirus, the U.S., for example, requested that HCQ be imported from India. The virus has also impacted Canada's medicine supply system, potentially causing complications for patients. The increasing importance of generics, rise in consumption of biopharmaceuticals, and expanding drug research and development activities for drug manufacturing are the primary drivers driving the growth of the market. However, the market's expansion is likely to be hampered by unfavorable drug price control regimes in several countries and high manufacturing costs.
Developing nations like India are receiving an increased preference in the market over dominant API market countries, like China, owing to geopolitical situations. Furthermore, India has quality raw materials and products, a large workforce, a vast distribution network, and government subsidies through the "Make in India" program.
To address unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In November 2021, Merck & Co Inc. announced that it has acquired Acceleron Pharma, this acquisition would help Merck & Co to expand their cardiovascular portfolio and pipeline.
Active Pharmaceutical Ingredients Market Report Highlights
- The innovative APIs segment dominated the market in terms of the revenue share of 66.3% in 2021, owing to increasing research and development activities for novel drug development and positive government initiatives
- The cardiovascular disease segment held the largest revenue share of 19.5% in 2021, attributed to the rising prevalence of target disease globally
- The synthetic API segment dominated the market with the largest revenue share of 72.6% in 2021, owing to the higher availability of raw materials and easier protocols for the synthesis of these molecules
- North America accounted for the largest revenue share of 39.0% in 2021 and is expected to maintain its lead over the forecast period. This is attributed to the rising epidemiology of cancer, along with other lifestyle-induced diseases, thus encouraging the R&D activities, thereby boosting the market growth
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation and Scope
1.1.1 Regional scope
1.1.2 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 Research Assumptions
1.8 Key KoL Responses
1.9 Market share calculations
1.10 List of Secondary Sources
1.11 List of Abbreviations
1.12 Objectives
1.12.1 Objective 1
1.12.2 Objective 2
1.12.3 Objective 3
1.12.4 Objective 4
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Segment Outlook
2.2 Competitive Outlook
2.3 Market Outlook
CHAPTER 3 API MARKET VARIABLES, TRENDS, AND SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 User Perspective Analysis
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Growing geriatric population
3.4.1.2 Rising prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
3.4.1.3 Increasing preference for targeted therapy approach in cancer treatment
3.4.1.4 Increasing preference for outsourcing APIs
3.4.2 Market Restraint Analysis
3.4.2.1 High capital investments and production cost
3.4.2.2 Stringent Safety and handling regulations regarding APIs
3.5 Market Analysis Tools
3.5.1 Industry Analysis: Porter’s Five Forces
3.5.2 PESTLE Analysis
3.5.3 Regulatory Scenario
CHAPTER 4 API MARKET: COMPETITIVE ANALYSIS
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.1.1 Ansoff matrix
4.1.2 Heat map analysis
4.2 Company Categorization
4.2.1 Innovators
4.2.2 Market Leaders
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key customers
4.3.3 Key company market share analysis, 2021
4.4 Public Companies
4.4.1 Company market position analysis
4.4.2 Company market position analysis
4.4.3 Competitive Dashboard Analysis
4.4.3.1 Market Differentiators
4.5 Private Companies
4.5.1 List of key emerging companies
4.6 Major Deals and Strategic Alliances Analysis
4.6.1 Joint Ventures
4.6.2 Acquisitions
4.6.3 Licensing and Partnerships
4.6.4 Technological Collaborations
CHAPTER 5 API MOLECULES OUTLOOK
5.1 Global Sales of API Molecules, USD Million, 2018 - 2020
5.2 Companies with the leading market position for API molecules
5.2.1 Amoxicillin
5.2.2 Azithromycin
5.2.3 Bleomycin
5.2.4 Caspofungin
5.2.5 Clarithromycin
5.2.6 Clavulanic acid
5.2.7 Clindamycin
5.2.8 Compactin (Mevastatin)
5.2.9 Cyclosporin
5.2.10 Dactinomycin
5.2.11 Daptomycin
5.2.12 Demeclocycline
5.2.13 Doxycycline
5.2.14 Erythromycin
5.2.15 Ivermectin (Avermectin)
5.2.16 Lovastatin
5.2.17 Micafungin
5.2.18 Minocycline
5.2.19 Mitomycin
5.2.20 Mycophenolic acid
5.2.21 Pneumocandin B0
5.2.22 Polymyxin
5.2.23 Pravastatin
5.2.24 Rapamycin (Sirolimus)
5.2.25 Simvastatin
5.2.26 Steroids
5.2.27 Tacrolimus
5.2.28 Tetracycline
5.2.29 Tigecycline
5.2.30 Tobramycin
5.2.31 Vancomycin
5.3 Comparative price analysis of the above-mentioned molecules
CHAPTER 6 API MARKET: SEGMENT ANALYSIS, BY TYPE OF SYNTHESIS, 2018 - 2030 (USD BILLION)
6.1 Definition and Scope
6.2 Type of Synthesis Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 Global API Market, by Type of Synthesis, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Biotech API
6.5.1.1 Biotech API market, 2018 - 2030 (USD Billion)
6.5.2 Monoclonal Antibodies
6.5.2.1 Monoclonal antibodies market, 2018 - 2030 (USD Billion)
6.5.3 Recombinant Proteins
6.5.3.1 Recombinant proteins market, 2018 - 2030 (USD Billion)
6.5.4 Vaccines
6.5.4.1 Vaccines market, 2018 - 2030 (USD Billion)
6.5.5 Synthetic API
6.5.5.1 Synthetic API market, 2018 - 2030 (USD Billion)
CHAPTER 7 API MARKET: SEGMENT ANALYSIS, BY TYPE OF MANUFACTURER, 2018 - 2030 (USD BILLION)
7.1 Definition and Scope
7.2 Type of Manufacturer Market Share Analysis, 2021 & 2030
7.3 Segment Dashboard
7.4 Global API Market, by Type of Manufacturers, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Captive API
7.5.1.1 Captive API market, 2018 - 2030 (USD Billion)
7.5.2 Merchant API
7.5.2.1 Captive API market, 2018 - 2030 (USD Billion)
CHAPTER 8 API MARKET: SEGMENT ANALYSIS, BY TYPE, 2018 - 2030 (USD BILLION)
8.1 Definition and Scope
8.2 Type Market Share Analysis, 2020 & 2030
8.3 Segment Dashboard
8.4 Global API Market, by Type, 2018 to 2030
8.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
8.5.1 Generic APIS
8.5.1.1 Generic APIs market, 2018 - 2030 (USD Billion)
8.5.2 Innovative APIs
8.5.2.1 Innovative APIS market, 2018 - 2030 (USD Billion)
CHAPTER 9 API MARKET: SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD BILLION)
9.1 Definition and Scope
9.2 Application Market Share Analysis, 2021 & 2030
9.3 Segment Dashboard
9.4 Global API Market, by Application, 2018 to 2030
9.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
9.5.1 Cardiovascular Diseases
9.5.1.1 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
9.5.2 Oncology
9.5.2.1 Oncology market, 2018 - 2030 (USD Billion)
9.5.3 CNS and Neurology
9.5.3.1 CNS and neurology market, 2018 - 2030 (USD Billion)
9.5.4 Orthopedics
9.5.4.1 Orthopedics market, 2018 - 2030 (USD Billion)
9.5.5 Endocrinology
9.5.5.1 Endocrinology market, 2018 - 2030 (USD Billion)
9.5.6 Pulmonology
9.5.6.1 Pulmonology market, 2018 - 2030 (USD Billion)
9.5.7 Gastroenterology
9.5.7.1 Gastroenterology market, 2018 - 2030 (USD Billion)
9.5.8 Nephrology
9.5.8.1 Nephrology market, 2018 - 2030 (USD Billion)
9.5.9 Ophthalmology
9.5.9.1 Ophthalmology market, 2018 - 2030 (USD Billion)
9.5.10 Others
9.5.10.1 Others market, 2018 - 2030 (USD Billion)
CHAPTER 10 API MARKET: REGIONAL MARKET ANALYSIS, 2018 - 2030 (USD BILLION)
10.1 Definition & Scope
10.2 Regional Market Share Analysis, 2021 & 2030
10.3 Regional Market Dashboard
10.4 Regional Market Snapshot
10.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
10.5.1 North America
10.5.2 Europe
10.5.3 Asia Pacific
10.5.4 Latin America
10.5.5 MEA
10.6 Market Size, & Forecasts, Trend Analysis, 2018 to 2030
10.7 North America
10.7.1 North America Market estimates and forecast, 2018 - 2030 (USD Billion)
10.7.2 U.S.
10.7.2.1 U.S. API market, 2018 - 2030 (USD Billion)
10.7.3 Canada
10.7.3.1 Canada API market, 2018 - 2030 (USD Billion)
10.8 Europe
10.8.1 Europe API market, 2018 - 2030 (USD Billion)
10.8.2 U.K.
10.8.2.1 U.K. API market, 2018 - 2030 (USD Billion)
10.8.3 Germany
10.8.3.1 Germany API market, 2018 - 2030 (USD Billion)
10.8.4 Spain
10.8.4.1 Spain API market, 2018 - 2030 (USD Billion)
10.8.5 France
10.8.5.1 France API market, 2018 - 2030 (USD Billion)
10.8.6 Italy
10.8.6.1 Italy API market, 2018 - 2030 (USD Billion)
10.8.7 Russia
10.8.7.1 Russia API market, 2018 - 2030 (USD Billion)
10.9 Asia Pacific
10.9.1 Asia Pacific API market, 2018 - 2030 (USD Billion)
10.9.2 Japan
10.9.2.1 Japan API market, 2018 - 2030 (USD Billion)
10.9.3 China
10.9.3.1 China API market, 2018 - 2030 (USD Billion)
10.9.4 India
10.9.4.1 India API market, 2018 - 2030 (USD Billion)
10.9.5 South Korea
10.9.5.1 South Korea API market, 2018 - 2030 (USD Billion)
10.9.6 Australia
10.9.6.1 Australia API market, 2018 - 2030 (USD Billion)
10.10 Latin America
10.10.1 Latin America API Market, 2018 - 2030 (USD Billion)
10.10.2 Brazil
10.10.2.1 Brazil API market, 2018 - 2030 (USD Billion)
10.10.3 Mexico
10.10.3.1 Mexico API market, 2018 - 2030 (USD Billion)
10.10.4 Argentina
10.10.4.1 Argentina API market, 2018 - 2030 (USD Billion)
10.11 MEA
10.11.1 MEA API market, 2018 - 2030 (USD Billion)
10.11.2 South Africa
10.11.2.1 South Africa API market, 2018 - 2030 (USD Billion)
10.11.3 Saudi Arabia
10.11.3.1 Saudi Arabia API market, 2018 - 2030 (USD Billion)
10.11.4 UAE
10.11.4.1 UAE API market, 2018 - 2030 (USD Billion)
CHAPTER 11 COMPANY PROFILES
11.1 AbbVie, Inc.
11.1.1 Company overview
11.1.2 Financial performance
11.1.3 Product benchmarking
11.1.4 Strategic initiatives
11.2 Boehringer Ingelheim International GmbH
11.2.1 Company overview
11.2.2 Financial performance
11.2.3 Product benchmarking
11.2.4 Strategic initiatives
11.3 Bristol-Myers Squibb Company
11.3.1 Company overview
11.3.2 Financial performance
11.3.3 Product benchmarking
11.3.4 Strategic initiatives
11.4 Cipla, Inc.
11.4.1 Company overview
11.4.2 Financial performance
11.4.3 Product benchmarking
11.4.4 Strategic initiatives
11.5 Merck & Co., Inc.
11.5.1 Company overview
11.5.2 Financial performance
11.5.3 Product benchmarking
11.5.4 Strategic initiatives
11.6 Albemarle Corporation
11.6.1 Company overview
11.6.2 Financial performance
11.6.3 Product benchmarking
11.7 Aurobindo Pharma
11.7.1 Company overview
11.7.2 Financial performance
11.7.3 Product benchmarking
11.7.4 Strategic initiatives
11.8 Viatris Inc. (Mylan N.V.)
11.8.1 Company overview
11.8.2 Financial performance
11.8.3 Product benchmarking
11.8.4 Strategic initiatives
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Company overview
11.9.2 Financial performance
11.9.3 Product benchmarking
11.9.4 Strategic initiatives
11.10 Sun Pharmaceutical Industries Ltd.
11.10.1 Company overview
11.10.2 Financial performance
11.10.3 Product benchmarking
11.10.4 Strategic initiatives
11.11 Dr. Reddy’s Laboratories Ltd.
11.11.1 Company overview
11.11.2 Financial performance
11.11.3 Product benchmarking
11.11.4 Strategic initiatives
1.1 Market Segmentation and Scope
1.1.1 Regional scope
1.1.2 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 Research Assumptions
1.8 Key KoL Responses
1.9 Market share calculations
1.10 List of Secondary Sources
1.11 List of Abbreviations
1.12 Objectives
1.12.1 Objective 1
1.12.2 Objective 2
1.12.3 Objective 3
1.12.4 Objective 4
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Segment Outlook
2.2 Competitive Outlook
2.3 Market Outlook
CHAPTER 3 API MARKET VARIABLES, TRENDS, AND SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 User Perspective Analysis
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Growing geriatric population
3.4.1.2 Rising prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
3.4.1.3 Increasing preference for targeted therapy approach in cancer treatment
3.4.1.4 Increasing preference for outsourcing APIs
3.4.2 Market Restraint Analysis
3.4.2.1 High capital investments and production cost
3.4.2.2 Stringent Safety and handling regulations regarding APIs
3.5 Market Analysis Tools
3.5.1 Industry Analysis: Porter’s Five Forces
3.5.2 PESTLE Analysis
3.5.3 Regulatory Scenario
CHAPTER 4 API MARKET: COMPETITIVE ANALYSIS
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.1.1 Ansoff matrix
4.1.2 Heat map analysis
4.2 Company Categorization
4.2.1 Innovators
4.2.2 Market Leaders
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key customers
4.3.3 Key company market share analysis, 2021
4.4 Public Companies
4.4.1 Company market position analysis
4.4.2 Company market position analysis
4.4.3 Competitive Dashboard Analysis
4.4.3.1 Market Differentiators
4.5 Private Companies
4.5.1 List of key emerging companies
4.6 Major Deals and Strategic Alliances Analysis
4.6.1 Joint Ventures
4.6.2 Acquisitions
4.6.3 Licensing and Partnerships
4.6.4 Technological Collaborations
CHAPTER 5 API MOLECULES OUTLOOK
5.1 Global Sales of API Molecules, USD Million, 2018 - 2020
5.2 Companies with the leading market position for API molecules
5.2.1 Amoxicillin
5.2.2 Azithromycin
5.2.3 Bleomycin
5.2.4 Caspofungin
5.2.5 Clarithromycin
5.2.6 Clavulanic acid
5.2.7 Clindamycin
5.2.8 Compactin (Mevastatin)
5.2.9 Cyclosporin
5.2.10 Dactinomycin
5.2.11 Daptomycin
5.2.12 Demeclocycline
5.2.13 Doxycycline
5.2.14 Erythromycin
5.2.15 Ivermectin (Avermectin)
5.2.16 Lovastatin
5.2.17 Micafungin
5.2.18 Minocycline
5.2.19 Mitomycin
5.2.20 Mycophenolic acid
5.2.21 Pneumocandin B0
5.2.22 Polymyxin
5.2.23 Pravastatin
5.2.24 Rapamycin (Sirolimus)
5.2.25 Simvastatin
5.2.26 Steroids
5.2.27 Tacrolimus
5.2.28 Tetracycline
5.2.29 Tigecycline
5.2.30 Tobramycin
5.2.31 Vancomycin
5.3 Comparative price analysis of the above-mentioned molecules
CHAPTER 6 API MARKET: SEGMENT ANALYSIS, BY TYPE OF SYNTHESIS, 2018 - 2030 (USD BILLION)
6.1 Definition and Scope
6.2 Type of Synthesis Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 Global API Market, by Type of Synthesis, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Biotech API
6.5.1.1 Biotech API market, 2018 - 2030 (USD Billion)
6.5.2 Monoclonal Antibodies
6.5.2.1 Monoclonal antibodies market, 2018 - 2030 (USD Billion)
6.5.3 Recombinant Proteins
6.5.3.1 Recombinant proteins market, 2018 - 2030 (USD Billion)
6.5.4 Vaccines
6.5.4.1 Vaccines market, 2018 - 2030 (USD Billion)
6.5.5 Synthetic API
6.5.5.1 Synthetic API market, 2018 - 2030 (USD Billion)
CHAPTER 7 API MARKET: SEGMENT ANALYSIS, BY TYPE OF MANUFACTURER, 2018 - 2030 (USD BILLION)
7.1 Definition and Scope
7.2 Type of Manufacturer Market Share Analysis, 2021 & 2030
7.3 Segment Dashboard
7.4 Global API Market, by Type of Manufacturers, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Captive API
7.5.1.1 Captive API market, 2018 - 2030 (USD Billion)
7.5.2 Merchant API
7.5.2.1 Captive API market, 2018 - 2030 (USD Billion)
CHAPTER 8 API MARKET: SEGMENT ANALYSIS, BY TYPE, 2018 - 2030 (USD BILLION)
8.1 Definition and Scope
8.2 Type Market Share Analysis, 2020 & 2030
8.3 Segment Dashboard
8.4 Global API Market, by Type, 2018 to 2030
8.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
8.5.1 Generic APIS
8.5.1.1 Generic APIs market, 2018 - 2030 (USD Billion)
8.5.2 Innovative APIs
8.5.2.1 Innovative APIS market, 2018 - 2030 (USD Billion)
CHAPTER 9 API MARKET: SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD BILLION)
9.1 Definition and Scope
9.2 Application Market Share Analysis, 2021 & 2030
9.3 Segment Dashboard
9.4 Global API Market, by Application, 2018 to 2030
9.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
9.5.1 Cardiovascular Diseases
9.5.1.1 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
9.5.2 Oncology
9.5.2.1 Oncology market, 2018 - 2030 (USD Billion)
9.5.3 CNS and Neurology
9.5.3.1 CNS and neurology market, 2018 - 2030 (USD Billion)
9.5.4 Orthopedics
9.5.4.1 Orthopedics market, 2018 - 2030 (USD Billion)
9.5.5 Endocrinology
9.5.5.1 Endocrinology market, 2018 - 2030 (USD Billion)
9.5.6 Pulmonology
9.5.6.1 Pulmonology market, 2018 - 2030 (USD Billion)
9.5.7 Gastroenterology
9.5.7.1 Gastroenterology market, 2018 - 2030 (USD Billion)
9.5.8 Nephrology
9.5.8.1 Nephrology market, 2018 - 2030 (USD Billion)
9.5.9 Ophthalmology
9.5.9.1 Ophthalmology market, 2018 - 2030 (USD Billion)
9.5.10 Others
9.5.10.1 Others market, 2018 - 2030 (USD Billion)
CHAPTER 10 API MARKET: REGIONAL MARKET ANALYSIS, 2018 - 2030 (USD BILLION)
10.1 Definition & Scope
10.2 Regional Market Share Analysis, 2021 & 2030
10.3 Regional Market Dashboard
10.4 Regional Market Snapshot
10.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
10.5.1 North America
10.5.2 Europe
10.5.3 Asia Pacific
10.5.4 Latin America
10.5.5 MEA
10.6 Market Size, & Forecasts, Trend Analysis, 2018 to 2030
10.7 North America
10.7.1 North America Market estimates and forecast, 2018 - 2030 (USD Billion)
10.7.2 U.S.
10.7.2.1 U.S. API market, 2018 - 2030 (USD Billion)
10.7.3 Canada
10.7.3.1 Canada API market, 2018 - 2030 (USD Billion)
10.8 Europe
10.8.1 Europe API market, 2018 - 2030 (USD Billion)
10.8.2 U.K.
10.8.2.1 U.K. API market, 2018 - 2030 (USD Billion)
10.8.3 Germany
10.8.3.1 Germany API market, 2018 - 2030 (USD Billion)
10.8.4 Spain
10.8.4.1 Spain API market, 2018 - 2030 (USD Billion)
10.8.5 France
10.8.5.1 France API market, 2018 - 2030 (USD Billion)
10.8.6 Italy
10.8.6.1 Italy API market, 2018 - 2030 (USD Billion)
10.8.7 Russia
10.8.7.1 Russia API market, 2018 - 2030 (USD Billion)
10.9 Asia Pacific
10.9.1 Asia Pacific API market, 2018 - 2030 (USD Billion)
10.9.2 Japan
10.9.2.1 Japan API market, 2018 - 2030 (USD Billion)
10.9.3 China
10.9.3.1 China API market, 2018 - 2030 (USD Billion)
10.9.4 India
10.9.4.1 India API market, 2018 - 2030 (USD Billion)
10.9.5 South Korea
10.9.5.1 South Korea API market, 2018 - 2030 (USD Billion)
10.9.6 Australia
10.9.6.1 Australia API market, 2018 - 2030 (USD Billion)
10.10 Latin America
10.10.1 Latin America API Market, 2018 - 2030 (USD Billion)
10.10.2 Brazil
10.10.2.1 Brazil API market, 2018 - 2030 (USD Billion)
10.10.3 Mexico
10.10.3.1 Mexico API market, 2018 - 2030 (USD Billion)
10.10.4 Argentina
10.10.4.1 Argentina API market, 2018 - 2030 (USD Billion)
10.11 MEA
10.11.1 MEA API market, 2018 - 2030 (USD Billion)
10.11.2 South Africa
10.11.2.1 South Africa API market, 2018 - 2030 (USD Billion)
10.11.3 Saudi Arabia
10.11.3.1 Saudi Arabia API market, 2018 - 2030 (USD Billion)
10.11.4 UAE
10.11.4.1 UAE API market, 2018 - 2030 (USD Billion)
CHAPTER 11 COMPANY PROFILES
11.1 AbbVie, Inc.
11.1.1 Company overview
11.1.2 Financial performance
11.1.3 Product benchmarking
11.1.4 Strategic initiatives
11.2 Boehringer Ingelheim International GmbH
11.2.1 Company overview
11.2.2 Financial performance
11.2.3 Product benchmarking
11.2.4 Strategic initiatives
11.3 Bristol-Myers Squibb Company
11.3.1 Company overview
11.3.2 Financial performance
11.3.3 Product benchmarking
11.3.4 Strategic initiatives
11.4 Cipla, Inc.
11.4.1 Company overview
11.4.2 Financial performance
11.4.3 Product benchmarking
11.4.4 Strategic initiatives
11.5 Merck & Co., Inc.
11.5.1 Company overview
11.5.2 Financial performance
11.5.3 Product benchmarking
11.5.4 Strategic initiatives
11.6 Albemarle Corporation
11.6.1 Company overview
11.6.2 Financial performance
11.6.3 Product benchmarking
11.7 Aurobindo Pharma
11.7.1 Company overview
11.7.2 Financial performance
11.7.3 Product benchmarking
11.7.4 Strategic initiatives
11.8 Viatris Inc. (Mylan N.V.)
11.8.1 Company overview
11.8.2 Financial performance
11.8.3 Product benchmarking
11.8.4 Strategic initiatives
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Company overview
11.9.2 Financial performance
11.9.3 Product benchmarking
11.9.4 Strategic initiatives
11.10 Sun Pharmaceutical Industries Ltd.
11.10.1 Company overview
11.10.2 Financial performance
11.10.3 Product benchmarking
11.10.4 Strategic initiatives
11.11 Dr. Reddy’s Laboratories Ltd.
11.11.1 Company overview
11.11.2 Financial performance
11.11.3 Product benchmarking
11.11.4 Strategic initiatives
LIST OF TABLES
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global Active Pharmaceutical Ingredients Market, By Region, 2018 - 2030 (USD Billion)
TABLE 5 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 6 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 7 Global Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 8 Global Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 9 North America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 10 North America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 11 North America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 12 North America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 13 North America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 14 U.S. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 15 U.S. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 16 U.S. Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 17 U.S. Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 18 Canada Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 19 Canada Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 20 Canada Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 21 Canada Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 22 Europe Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 23 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 24 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 25 Europe Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 26 Europe Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 27 U.K. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 28 U.K. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 29 U.K. Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 30 U.K. Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 31 Germany Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 32 Germany Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 33 Germany America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 34 Germany America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 35 France Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 36 France Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 37 France Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 38 France Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 39 Spain Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 40 Spain Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 41 Spain Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 42 Spain Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 43 Italy Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 44 Italy Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 45 Italy Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 46 Italy Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 47 Russia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 48 Russia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 49 Russia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 50 Russia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 51 Asia Pacific Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 52 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 53 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 54 Asia Pacific Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 55 Asia Pacific Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 56 China Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 57 China Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 58 China Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 59 China Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 60 Japan Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 61 Japan Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 62 Japan Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 63 Japan Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 64 India Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 65 India Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 66 India Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 67 India Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 68 South Korea Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 69 South Korea Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 70 South Korea Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 71 South Korea Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 72 Australia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 73 Australia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 74 Australia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 75 Australia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 76 Latin America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 77 Latin America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 78 Latin America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 79 Latin America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 80 Latin America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 81 Brazil Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 82 Brazil Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 83 Brazil Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 84 Brazil Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 85 Mexico Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 86 Mexico Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 87 Mexico Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 88 Mexico Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 89 Argentina Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 90 Argentina Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 91 Argentina Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 92 Argentina Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 93 MEA Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 94 MEA Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 95 MEA Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 96 MEA Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 97 MEA Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 98 South Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 99 South Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 100 South Africa Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 101 South Africa Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 102 UAE Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 103 UAE Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 104 UAE Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 105 UAE Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 106 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 107 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 108 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 109 Saudi Arabia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global Active Pharmaceutical Ingredients Market, By Region, 2018 - 2030 (USD Billion)
TABLE 5 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 6 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 7 Global Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 8 Global Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 9 North America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 10 North America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 11 North America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 12 North America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 13 North America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 14 U.S. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 15 U.S. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 16 U.S. Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 17 U.S. Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 18 Canada Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 19 Canada Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 20 Canada Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 21 Canada Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 22 Europe Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 23 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 24 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 25 Europe Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 26 Europe Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 27 U.K. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 28 U.K. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 29 U.K. Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 30 U.K. Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 31 Germany Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 32 Germany Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 33 Germany America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 34 Germany America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 35 France Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 36 France Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 37 France Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 38 France Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 39 Spain Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 40 Spain Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 41 Spain Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 42 Spain Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 43 Italy Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 44 Italy Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 45 Italy Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 46 Italy Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 47 Russia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 48 Russia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 49 Russia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 50 Russia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 51 Asia Pacific Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 52 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 53 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 54 Asia Pacific Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 55 Asia Pacific Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 56 China Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 57 China Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 58 China Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 59 China Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 60 Japan Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 61 Japan Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 62 Japan Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 63 Japan Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 64 India Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 65 India Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 66 India Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 67 India Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 68 South Korea Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 69 South Korea Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 70 South Korea Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 71 South Korea Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 72 Australia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 73 Australia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 74 Australia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 75 Australia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 76 Latin America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 77 Latin America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 78 Latin America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 79 Latin America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 80 Latin America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 81 Brazil Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 82 Brazil Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 83 Brazil Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 84 Brazil Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 85 Mexico Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 86 Mexico Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 87 Mexico Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 88 Mexico Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 89 Argentina Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 90 Argentina Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 91 Argentina Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 92 Argentina Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 93 MEA Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 94 MEA Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 95 MEA Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 96 MEA Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 97 MEA Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 98 South Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 99 South Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 100 South Africa Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 101 South Africa Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 102 UAE Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 103 UAE Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 104 UAE Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 105 UAE Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 106 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 107 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 108 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 109 Saudi Arabia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
LIST OF FIGURES
FIG. 1 API market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 API market, segment outlook
FIG. 10 API market, competitive outlook
FIG. 11 API market outlook (2021)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 User perspective analysis
FIG. 14 Market driver relevance analysis (Current & future impact)
FIG. 15 Global percentage of the population, by age group, 2050 and 2000
FIG. 16 Market restraint relevance analysis (Current & future impact)
FIG. 17 Porter’s five forces analysis
FIG. 18 PESTLE analysis
FIG. 19 Ansoff Matrix
FIG. 20 Heat map analysis
FIG. 21 Company market position analysis
FIG. 22 Company market position analysis
FIG. 23 Market differentiators
FIG. 24 Strategy mapping
FIG. 25 API market: Type of synthesis movement analysis
FIG. 26 Segment dashboard
FIG. 27 API market type of synthesis outlook: Key takeaways
FIG. 28 Biotech API market, 2018 - 2030 (USD Billion)
FIG. 29 Monoclonal antibodies market, 2018 - 2030 (USD Billion)
FIG. 30 Recombinant proteins market, 2018 - 2030 (USD Billion)
FIG. 31 Vaccines market, 2018 - 2030 (USD Billion)
FIG. 32 Synthetic API market, 2018 - 2030 (USD Billion)
FIG. 33 API market: Type of manufacturers movement analysis
FIG. 34 Segment dashboard
FIG. 35 API market type of manufacturers outlook: Key takeaways
FIG. 36 Captive API market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 37 Merchant API market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 38 API market: Type movement analysis
FIG. 39 Segment dashboard
FIG. 40 API market type outlook: Key takeaways
FIG. 41 Generic APIs market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 42 Innovative APIs market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 43 API market: Application movement analysis
FIG. 44 Segment dashboard
FIG. 45 API market application outlook: Key takeaways
FIG. 46 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 47 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 48 CNS & neurology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 49 Orthopedics market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 50 Endocrinology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 51 Pulmonology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 52 Gastroenterology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 53 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 54 Ophthalmology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 55 Others market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 56 Regional outlook, 2021 & 2030
FIG. 57 Regional market dashboard
FIG. 58 Regional marketplace: Key takeaways
FIG. 59 North America, SWOT Analysis
FIG. 60 Europe, SWOT Analysis
FIG. 61 Asia Pacific, SWOT Analysis
FIG. 62 Latin America, SWOT Analysis
FIG. 63 MEA, SWOT Analysis
FIG. 64 North America
FIG. 65 North America market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 66 U.S.
FIG. 67 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 68 Canada
FIG. 69 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 70 Europe
FIG. 71 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 72 U.K.
FIG. 73 U.K. market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 74 Germany
FIG. 75 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 76 Spain
FIG. 77 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 78 France
FIG. 79 France market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 80 Italy
FIG. 81 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 82 Russia
FIG. 83 Russia market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 84 Asia Pacific
FIG. 85 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 86 Japan
FIG. 87 Japan market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 88 China
FIG. 89 China market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 90 India
FIG. 91 India market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 92 South Korea
FIG. 93 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 94 Australia
FIG. 95 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 96 Latin America
FIG. 97 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 98 Brazil
FIG. 99 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 100 Mexico
FIG. 101 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 102 Argentina
FIG. 103 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 104 MEA
FIG. 105 MEA market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 106 South Africa
FIG. 107 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 108 Saudi Arabia
FIG. 109 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 110 UAE
FIG. 111 UAE market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 1 API market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 API market, segment outlook
FIG. 10 API market, competitive outlook
FIG. 11 API market outlook (2021)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 User perspective analysis
FIG. 14 Market driver relevance analysis (Current & future impact)
FIG. 15 Global percentage of the population, by age group, 2050 and 2000
FIG. 16 Market restraint relevance analysis (Current & future impact)
FIG. 17 Porter’s five forces analysis
FIG. 18 PESTLE analysis
FIG. 19 Ansoff Matrix
FIG. 20 Heat map analysis
FIG. 21 Company market position analysis
FIG. 22 Company market position analysis
FIG. 23 Market differentiators
FIG. 24 Strategy mapping
FIG. 25 API market: Type of synthesis movement analysis
FIG. 26 Segment dashboard
FIG. 27 API market type of synthesis outlook: Key takeaways
FIG. 28 Biotech API market, 2018 - 2030 (USD Billion)
FIG. 29 Monoclonal antibodies market, 2018 - 2030 (USD Billion)
FIG. 30 Recombinant proteins market, 2018 - 2030 (USD Billion)
FIG. 31 Vaccines market, 2018 - 2030 (USD Billion)
FIG. 32 Synthetic API market, 2018 - 2030 (USD Billion)
FIG. 33 API market: Type of manufacturers movement analysis
FIG. 34 Segment dashboard
FIG. 35 API market type of manufacturers outlook: Key takeaways
FIG. 36 Captive API market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 37 Merchant API market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 38 API market: Type movement analysis
FIG. 39 Segment dashboard
FIG. 40 API market type outlook: Key takeaways
FIG. 41 Generic APIs market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 42 Innovative APIs market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 43 API market: Application movement analysis
FIG. 44 Segment dashboard
FIG. 45 API market application outlook: Key takeaways
FIG. 46 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 47 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 48 CNS & neurology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 49 Orthopedics market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 50 Endocrinology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 51 Pulmonology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 52 Gastroenterology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 53 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 54 Ophthalmology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 55 Others market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 56 Regional outlook, 2021 & 2030
FIG. 57 Regional market dashboard
FIG. 58 Regional marketplace: Key takeaways
FIG. 59 North America, SWOT Analysis
FIG. 60 Europe, SWOT Analysis
FIG. 61 Asia Pacific, SWOT Analysis
FIG. 62 Latin America, SWOT Analysis
FIG. 63 MEA, SWOT Analysis
FIG. 64 North America
FIG. 65 North America market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 66 U.S.
FIG. 67 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 68 Canada
FIG. 69 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 70 Europe
FIG. 71 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 72 U.K.
FIG. 73 U.K. market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 74 Germany
FIG. 75 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 76 Spain
FIG. 77 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 78 France
FIG. 79 France market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 80 Italy
FIG. 81 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 82 Russia
FIG. 83 Russia market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 84 Asia Pacific
FIG. 85 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 86 Japan
FIG. 87 Japan market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 88 China
FIG. 89 China market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 90 India
FIG. 91 India market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 92 South Korea
FIG. 93 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 94 Australia
FIG. 95 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 96 Latin America
FIG. 97 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 98 Brazil
FIG. 99 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 100 Mexico
FIG. 101 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 102 Argentina
FIG. 103 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 104 MEA
FIG. 105 MEA market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 106 South Africa
FIG. 107 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 108 Saudi Arabia
FIG. 109 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 110 UAE
FIG. 111 UAE market estimates and forecast, 2018 - 2030 (USD Billion)
